D007166Chemicals & DrugsD27.505.696.477.65656013800.614566Immunosuppressive AgentsFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentDivisionvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonInfectious Diseases, Infection Control, and Employee HealthStem Cell TransplantationMD AndersonRICHARD ECHAMPLINRICHARD E CHAMPLIN8508CHAMPLIN, RICHARD EProfessorDIMITRIOS PKONTOYIANNISDIMITRIOS P KONTOYIANNIS8761KONTOYIANNIS, DIMITRIOS PProfessorSTEFAN OCTAVIANCIUREASTEFAN OCTAVIAN CIUREA9422CIUREA, STEFAN OCTAVIANAssociate Professor74Professor14Associate Professor53Graduate Student3.048070.000953422560research area of0.9384050.00588995893subject area forDepartment of OphthalmologyOphthalmologyBaylor College of MedicineSTEPHENPFLUGFELDERSTEPHEN PFLUGFELDER29.70508570000000-95.40180870000000167PFLUGFELDER, STEPHENProfessortrue1ProfessorProfessor34361671Ali G, Cuny GDMolecules (Basel, Switzerland)8-, 9-, and 11-Aryloxy Dimeric Aporphines and Their Pharmacological Activities. Molecules. 2021 Jul 27; 26(15).Molecules2021-07-27T00:00:0020218-, 9-, and 11-Aryloxy Dimeric Aporphines and Their Pharmacological Activities.34431142Arrabi L, Jan A, Hosing C, Milton DR, Yeh JEuropean journal of haematologyTransitioning tacrolimus to sirolimus in allogeneic hematopoietic cell transplantation. Eur J Haematol. 2021 Dec; 107(6):634-641.Eur J Haematol2021-08-31T00:00:002021Transitioning tacrolimus to sirolimus in allogeneic hematopoietic cell transplantation.34855460Luznik L, Pasquini MC, Logan B, Soiffer RJ, Wu J, Devine SM, Geller N, Giralt S, Heslop HE, Horowitz MM, Jones RJ, Litzow MR, Mendizabal A, Muffly L, Nemecek ER, O'Donnell L, O'Reilly RJ, Palencia R, Schetelig J, Shune L, Solomon SR, Vasu S, Ho VT, Perales MAJournal of clinical oncology : official journal of the American Society of Clinical OncologyRandomized Phase III BMT CTN Trial of Calcineurin Inhibitor-Free Chronic Graft-Versus-Host Disease Interventions in Myeloablative Hematopoietic Cell Transplantation for Hematologic Malignancies. J Clin Oncol. 2022 02 01; 40(4):356-368.J Clin Oncol2021-12-02T00:00:002021Randomized Phase III BMT CTN Trial of Calcineurin Inhibitor-Free Chronic Graft-Versus-Host Disease Interventions in Myeloablative Hematopoietic Cell Transplantation for Hematologic Malignancies.34848501Sullivan R, Kilaru A, Hemmer B, Campbell Cree BA, Greenberg BM, Kundu U, Hach T, DeLasHeras V, Ward BJ, Berger JNeurology(R) neuroimmunology & neuroinflammationCOVID-19 Infection in Fingolimod- or Siponimod-Treated Patients: Case Series. Neurol Neuroimmunol Neuroinflamm. 2021 11; 9(1).Neurol Neuroimmunol Neuroinflamm2021-11-30T00:00:002021COVID-19 Infection in Fingolimod- or Siponimod-Treated Patients: Case Series.Biomedical Sciences & Health Equitytrue1Graduate StudentGraduate StudentPaulCarpenterPaul Carpenter18953Carpenter, PaulGraduate Student37348193Malani Shukla N, Casper TC, Ness J, Wheeler Y, Chitnis T, Lotze T, Gorman M, Benson L, Weinstock-Guttmann B, Aaen G, Rodriguez M, Tillema JM, Krupp L, Schreiner T, Mar S, Goyal M, Rensel M, Abrams A, Rose J, Waltz M, Liu T, Manlius C, Waubant E, U.S. Network of Pediatric Multiple Sclerosis CentersPediatric neurologyDemographic Features and Clinical Course of Patients With Pediatric-Onset Multiple Sclerosis on Newer Disease-Modifying Treatments. Pediatr Neurol. 2023 Aug; 145:125-131.Pediatr Neurol2023-04-28T00:00:002023Demographic Features and Clinical Course of Patients With Pediatric-Onset Multiple Sclerosis on Newer Disease-Modifying Treatments.true1ProfessorProfessortrue1Associate ProfessorAssociate Professortrue1ProfessorProfessor